The focal amplification of ZFP36L2 super-enhancers was observed in our cohort, as well as the HK, the TCGA GC, and the EAC cohorts, but not in ESCC, the ZFP36L2 super-enhancer was hypermethylated13. This evidence concerns the gene ZFP36L2 and esophageal squamous cell carcinoma.